Baseline scintigraphic abnormalities by myocardial perfusion imaging predict echocardiographic response to cardiac

Evan C Adelstein1, Samir Saba

  • 1Cardiovascular Institute, Department of Medicine, University of Pittsburgh, Medical Center, Pittsburgh, PA 15213-2582, USA.

Clinical Cardiology
|May 14, 2008
PubMed

Insights

Myocardial perfusion defects negatively impact cardiac resynchronization therapy (CRT) response in nonischemic cardiomyopathy (NICM). Patients with fewer perfusion defects showed better CRT echocardiographic outcomes, highlighting the importance of perfusion imaging in NICM.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Heart Failure Treatment

Background:

  • Myocardial scarring impacts cardiac resynchronization therapy (CRT) response in coronary artery disease.
  • The effect of perfusion abnormalities in nonischemic cardiomyopathy (NICM) on CRT outcomes is not well-defined.

Purpose of the Study:

  • To investigate how myocardial perfusion abnormalities affect echocardiographic outcomes of CRT in NICM patients.
  • To determine if resting perfusion defects influence CRT efficacy in nonischemic cardiomyopathy.

Main Methods:

  • Included 21 NICM patients undergoing CRT implantation and Thallium-201 SPECT myocardial perfusion imaging (MPI).
  • Quantitatively assessed perfusion using a summed perfusion score (SPS) for 17 myocardial segments.
  • Evaluated echocardiographic response (LVEF increase) before and after CRT in 15 patients.

Main Results:

  • Echocardiographic response to CRT was observed in 53.3% of patients.
  • Patients with a lower SPS (<=6) had a significantly higher response rate (100%) compared to those with higher SPS (>6) (30.0%) (OR 3.33, p=0.01).
  • All non-responders exhibited inferior perfusion defects; defect density near the LV lead did not significantly affect CRT efficacy.

Conclusions:

  • Significant myocardial perfusion defects are associated with a poorer echocardiographic response to CRT in NICM.
  • These findings suggest that MPI may help predict CRT response in NICM patients.
  • Prospective studies and histopathological correlation are recommended for confirmation.
Abstract